Role of Macrophages in CBD mediated attenuation of SEB-induced ARDS
巨噬细胞在 CBD 介导的 SEB 诱导的 ARDS 减弱中的作用
基本信息
- 批准号:10867560
- 负责人:
- 金额:$ 24.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAcute Respiratory Distress SyndromeAdvisory CommitteesAffectAlveolarAlveolar MacrophagesAmericanAmino Acid SequenceAnti-Inflammatory AgentsApoptoticAttenuatedBacteriaBiological AssayBiological MarkersBiological ModelsBiometryC3H/HeJ MouseCCAAT-Enhancer-Binding ProteinsCCL17 geneCD14 geneCOVID-19COVID-19 mortalityCOVID-19 patientCRISPR/Cas technologyCXCL9 geneCannabidiolCannabinoidsCannabisCell LineCellsCellular InfiltrationCharacteristicsClinicalDNADataDiseaseDropsEndothelial CellsEnvironmentEpigenetic ProcessEpithelial CellsEvaluationFCGR3B geneGene ActivationGene ExpressionGenesGeneticGenetic TranscriptionHumanHypoxiaImmuneImmunologicsInfectionInfiltrationInflammatoryInflammatory ResponseInhalationInterleukin-1 betaInterleukin-12Interleukin-6Liquid substanceLungMacrophageMacrophage ActivationMarijuanaMediatingMentorsMicroRNAsModelingMononuclearMultiple Organ FailureMusOverdosePathway AnalysisPatientsPersonsPhagocytosisPlantsPlayPlethysmographyPrevention strategyPreventivePropertyPublic HealthPulmonary InflammationQuantitative Reverse Transcriptase PCRReporterResearchResearch PersonnelRoleSARS-CoV-2 spike proteinSepsisSeverity of illnessSiteSouth CarolinaStainsStaphylococcal Enterotoxin BStructureSuperantigensSurvival RateTNF geneTestingTetrahydrocannabinolTherapeuticToxinTrainingTraumaUniversitiesUp-RegulationVirusalveolar destructionattenuationcareer developmentcell typechemokinecytokinecytokine release syndromein silicoin vivoinsightinterleukin-23migrationmonocytemyeloid cell developmentneutrophilpandemic diseasepathogenphytocannabinoidpromoterprotein structurepulmonary functionreceptorsedativesevere COVID-19single cell sequencingtherapeutic developmenttranscription factor
项目摘要
PROJECT SUMMARY/ABSTRACT
The virus, SARS-CoV-2 has caused COVID-19 and claimed the lives of over 240,000 Americans and
1,270,000 people worldwide. Severe cases of the disease leads to Acute Respiratory Distress
Syndrome (ARDS), sepsis and can be fatal due to pulmonary inflammation and destruction of the
epithelial and endothelial cell lining. Understanding the mechanisms behind these diseases is vital to
develop effective preventive and therapeutic strategies. Staphylococcus enterotoxin B (SEB)-induced
ARDS mimics the cytokine storm, sepsis and multiple organ failure presented in patients with severe
COVID-19. It has been shown that the superantigen structure and sequence associated with the spike
protein of the SARS-CoV-2 is similar to that of SEB. This SEB-induced ARDS model also results in
various presentations of severity of illness in mice of different genetic backgrounds, as does COVID-
19 in humans. When C3H/HeJ mice are treated with SEB, their survival rate drops to 0%. In our study,
we found that Cannabidiol (CBD) administration following SEB treatment, led to 100% survival
indefinitely. Initial evaluation of whole single cell sequencing data comparing lungs from naïve with
SEB-induced ARDS mice illustrated that there was an increase in neutrophils, inflammatory
macrophages and pro-inflammatory cytokines (IL-1β and TNF-α) as well as a loss in lung epithelial
cells. To characterize the mechanism by which CBD treatment led to amelioration of the inflammatory
response, microRNA expression analysis was done that showed a significant decrease in expression
of miR-124-3p in SEB-treated group which is directly associated with upregulation of TNF-α and IL-1β
expression as well as macrophage activation gene, Cebp. We hypothesized that CBD attenuates SEB-
induced ARDS by miRNA dysregulation in lung-infiltrating cells, specifically by inducing miR-124-3p
which downregulates Cebp expression resulting in reduced activation of macrophages. Aim 1 will
elucidate the role of resident and monocyte-derived macrophages in disease and the effect CBD on
those subpopulations. Aim 2 will elucidate whether CBD affects Cebp expression and the effects that
miR-124-3p has on manifestation of disease. Aim 3 will determine the epigenetic factors regulating
expression of miR-124-3p. This study will explore CBD as a potential therapeutic for ARDS and/or
sepsis induced not only by SEB but other pathogens such as SARS-CoV-2. The K99R00 will provide
opportunities associated with Career Development and training in –omics approaches and biostatistics.
Taken together, my mentors, advisory committee, consultant, and research environment at the
University of South Carolina will nurture my successful transition to an Independent Investigator.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kiesha Wilson其他文献
Kiesha Wilson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kiesha Wilson', 18)}}的其他基金
Role of macrophages in CBD mediated attenuation of SEB-induced ARDS
巨噬细胞在 CBD 介导的 SEB 诱导的 ARDS 减弱中的作用
- 批准号:
10351483 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
Role of macrophages in CBD mediated attenuation of SEB-induced ARDS
巨噬细胞在 CBD 介导的 SEB 诱导的 ARDS 减弱中的作用
- 批准号:
10547783 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
相似海外基金
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Research Grant
The Association Between Aging, Inflammation, and Clinical Outcomes in Acute Respiratory Distress Syndrome
衰老、炎症与急性呼吸窘迫综合征临床结果之间的关联
- 批准号:
10722669 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Sedatives Pharmacology in Acute Respiratory Distress Syndrome- SPA
急性呼吸窘迫综合征中的镇静药理学 - SPA
- 批准号:
491387 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Fellowship Programs
New mechanism-based TREM-1 therapy for acute respiratory distress syndrome
基于新机制的 TREM-1 疗法治疗急性呼吸窘迫综合征
- 批准号:
10678788 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Great Lakes Clinical Center of the Acute Respiratory Distress Syndrome, Pneumonia and Sepsis (APS) Consortium
急性呼吸窘迫综合征、肺炎和败血症 (APS) 联盟五大湖临床中心
- 批准号:
10646578 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Effect of ADAMTS13 on pathogenesis of acute respiratory distress syndrome
ADAMTS13 对急性呼吸窘迫综合征发病机制的影响
- 批准号:
23K08447 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)
一种新型合成生物学衍生的微生物疗法,可治疗病毒引起的急性呼吸窘迫综合征(ARDS)
- 批准号:
10601865 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Development of drug therapy targeting ferroptosis, iron-dependent cell death for acute respiratory distress syndrome.
开发针对铁死亡(急性呼吸窘迫综合征的铁依赖性细胞死亡)的药物疗法。
- 批准号:
23K08360 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Sustainable Implementation of Prone Positioning for the Acute Respiratory Distress Syndrome
持续实施俯卧位治疗急性呼吸窘迫综合征
- 批准号:
10722194 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Point-of-care system to assess the risk of trauma-induced acute respiratory distress syndrome
用于评估创伤引起的急性呼吸窘迫综合征风险的护理点系统
- 批准号:
10594793 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:














{{item.name}}会员




